Surfactant Treatment of Late Preterm Infants during Emergency Transport: A Retrospective, Observational Study

Francesco Cavallin1, Giorgia Carlone2,3, Nicoletta Doglioni2

  • 1Independent Statistician, Solagna, Italy.

Neonatology
|September 27, 2021
PubMed

Insights

Administering surfactant to late preterm infants during emergency transport did not impact clinical outcomes. While delays in surfactant administration by the transport team slightly increased stabilization time, it did not compromise infant safety or overall health.

Area of Science:

  • Neonatal Medicine
  • Pediatric Respiratory Medicine
  • Transport Medicine

Background:

  • Respiratory distress syndrome (RDS) is common in late preterm infants requiring inter-hospital transport.
  • Optimizing surfactant administration timing is crucial for these vulnerable neonates.

Purpose of the Study:

  • To evaluate the effect of surfactant administration timing on clinical outcomes in late preterm infants undergoing emergency transport.
  • To identify optimal strategies for surfactant delivery during neonatal transfers.

Main Methods:

  • Retrospective analysis of 303 late preterm infants transported between 2005-2019.
  • Comparison of outcomes based on surfactant administration at referring hospital, by transport team, or at referral hospital.
  • Assessment of clinical complications, stabilization, respiratory support, and length of stay.

Main Results:

  • Surfactant was given to 51.1% of neonates at different stages of transport.
  • Longer stabilization time was observed when surfactant was administered by the transport team (17 min longer, p=0.01).
  • Greater oxygen reduction occurred with surfactant given at the referring hospital (-11%, p=0.01), with no significant differences in other outcomes.

Conclusions:

  • Delayed surfactant administration by transport teams did not negatively affect safety or clinical outcomes in late preterm infants.
  • Current timing strategies for surfactant delivery during transport appear safe and effective.
  • Further research may refine timing for improved respiratory support efficiency.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.9K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
238
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
631